ArticleAlzheimer's research & therapy2026
Cellular state heterogeneity underlying sex differences in Alzheimer's disease based on single-cell transcriptome.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAlzheimer's disease (AD) is a progressive neurodegenerative disorder that disproportionately affects women. However, the molecular mechanisms underlying sex differences in AD remain poorly understood.
methodsIn this study, we curated 3,302,741 single-nucleus or single-cell profiles from 603 samples (296 female and 307 male samples; 339 AD and 264 normal) across 10 cohorts to investigate sex-specific differences in the brain of individuals with and without AD. Focusing on six major cell types, we applied non-negative matrix factorization at the sample level to identify cell type -specific meta-programs (MPs). These MPs consist of mutually exclusive and functionally orthogonal gene set, representing different functional states of brain cells. Using these MPs, we characterized cellular states (CSs) across four sex-disease groups. We then examined sex differences in both AD and normal brains at the level of cellular states, with emphasis on metabolism, cell-cell communication, senescence, and disease relevance.
resultsMetabolic profiling revealed that inflammatory homeostasis is maintained through distinct metabolic pathways in males and females. Cell-cell communication analysis showed that the same cellular state interaction network is linked to AD pathology through sex-biased ligand-receptor pairs. Disease association analyses further indicated that polygenic risk for AD is not uniformly distributed across cell states, but instead shows sex-biased enrichment in specific neuronal and glial circuits. Senescence analysis suggested that males and females exhibit distinct CS-specific signatures of cellular senescence in AD. Additionally, we identified oligodendrocytes MP13 and excitatory neuron MP1 as sex-biased meta-programs.
conclusionsOverall, our study identified sex-biased MPs across six major cell types and revealed that females displayed greater vulnerability to Aβ and tau pathology, while males carry a higher genetic risk burdens. These findings highlight cellular state heterogeneity underlying sex differences in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.